久久婷婷国产综合精品,久久久久久久性潮,换脸国产av一区二区三区,韩国精品一区二区三区无码视频 ,久久久久成人精品无码

Basic Info
  • Grade: Pharmaceutical Grade

    Factory Location: Taizhou, Zhejiang, P.R.China

    Main Sales Markets: Eastern Europe,Asia,Middle East,Africa

  • Monthly Production Capacity: TBC

    Contract Manufacturing: CRO,CMO

  • Sample Provided: no

    Payment Terms: T/T

    Letrozole is approved to be used alone or with other drugs to treat:
    ? Breast cancer in postmenopausal women who have any of the following types of breast cancer--
    ? Early-stage , hormone receptor–positive (HR+) breast cancer that has been treated.
    ? Early-stage breast cancer that has been treated with tamoxifen citrate for at least 5 years.
    ? Breast cancer that is locally advanced or has metastasized (spread to other parts of the body) and is HR+. It is used as the first treatment.
    ? Breast cancer that is locally advanced or has metastasized and it is not known whether the cancer is HR+ or hormone receptor negative (HR-). It is used as the first treatment.
    ? Breast cancer that has gotten worse after antiestrogen therapy. It is used as the second treatment.
    Letrozole is also being studied in the treatment of other types of cancer.

Send your message to this supplier
  • From:
  • To:
    ZHEJIANG HISUN PHARMACEUTICAL CO.,LTD.
  • Send a Copy to this Email
  • Message:
    Upload Images / Files
    -?Supports?jpg,?jpeg,?png,
    ?gif,?pdf,?doc,?docx,
    ?xls,?xlsx,?txt,?rar?and?zip
    -?Max?upload?3?files;
    ?Max??total?size:?3MB
    (0/3)

    Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now

  • Verification:
PharmaSources Customer Service